Silver Book Fact

Growth hormone treatment in patients with fibromyalgia is effective in reducing pain with sustained action over time.

Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo. Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia. Pain. 2012; 153(7): 1382-9. http://www.ncbi.nlm.nih.gov/pubmed/22465047

Reference

Title
Growth Hormone Treatment for Sustained Pain Reduction and Improvement in Quality of Life in Severe Fibromyalgia
Publication
Pain
Publication Date
2012
Authors
Cuatrecasas, Guileem, C Alegre, J Fernandez-Sola, MJ Gonzalez, F Garcia-Fructuoso, V Poca-Dias, A Nadal, Gabriel Cuatrecasas, F Navarro, A Mera, M Lage, R Peino, F Casanueva, C Linan, G Sesmilo, MJ Coves, JP Izquierdo, I Alvarez, E Granadas, adn M Puig-Domingo
Volume & Issue
Volume 153, Issue 7
Pages
1382-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Antiepileptic drugs relieve persistent neuropathic pain. One meta-analysis found gabapentin to be associated with moderate benefit (equivalent to 30% pain relief) in close to 1 in 2 patients, and…  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • Brain imaging is showing that pain changes the structure and function of brain regions that perceive pain, making it persistent. These brain networks and receptor targets are being identified…  
  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.  
  • Resolvins, a family of lipid mediators, have shown potential in resolving persistent inflammatory pain.